Blog

Arguments that CHO host cells were considered unsuitable for commercial scale manufacturing unavailing because commercial scale was not a limitation in the claims.

May 16, 2017

Despite carve-out of patented indication, claims of induced patent infringement proceed to trial based on skinny label.

May 08, 2017

Mechanism of Action Claims Rejected based on Definition of "Therapeutically Effective Amount"

May 01, 2017

"Consisting of" strictly construed in pharmaceutical formulation claim.

February 19, 2017

Method of treating subpopulation of Parkinson's patients patentable even though same therapy for treatment of general Parkinson's populations was known.

January 22, 2017